The Phase I Market Overview and Outlook
$4,900.00 – $7,350.00
Related products
-
Select options This product has multiple variants. The options may be chosen on the product page
Post-marketing Safety Market Overview and Outlook
$4,900.00 – $7,350.00 -
Select options This product has multiple variants. The options may be chosen on the product page
Improving Patient Recruitment in Biosimilar Trials
$3,260.00 – $6,520.00 -
Select options This product has multiple variants. The options may be chosen on the product page
Improving Patient Recruitment and Feasibility: Recommendations from Site Coordinators
$4,900.00 – $7,350.00 -
Select options This product has multiple variants. The options may be chosen on the product page
CRO Selection for Small Pharma and Biotech (2011)
$2,460.00 – $3,690.00